BioCentury
ARTICLE | Company News

IURTC, Wake Forest, Chondrial deal

February 10, 2017 8:42 PM UTC

IURTC and Wake Forest’s Wake Forest Innovations commercialization arm granted Chondrial exclusive, worldwide rights to develop and commercialize preclinical Friedreich’s ataxia candidate CTI-1601. Dis...